Salbutamol
Salbutamol is an intervention with 87 clinical trials. Currently 7 active trials ongoing. Historical success rate of 93.8%.
Success Metrics
Based on 60 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
9
Mid Stage
44
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
92.3%
60 of 65 finished
7.7%
5 ended early
7
trials recruiting
87
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.
CF Bronchodilation
Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia
Study on Foster Efficacy Maintenance and Reliever vs Foster Maintenance + Salbutamol Reliever in Asthmatics (MART2)
Phosphodiesterase 4 Gene Variant and Salbutamol Response in Persistent Childhood Asthma
Clinical Trials (87)
Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.
CF Bronchodilation
Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia
Study on Foster Efficacy Maintenance and Reliever vs Foster Maintenance + Salbutamol Reliever in Asthmatics (MART2)
Phosphodiesterase 4 Gene Variant and Salbutamol Response in Persistent Childhood Asthma
Effects of Salbutamol in Athletes and Implications for Screening and Sports
5 Versus 10 Units of Insulin in Hyperkalemia Management
Beta Agonist Nebulization in Non Invasively Ventilated COPD Patients: Safety, and Therapeutic Efficacy Range.
the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)
Phase I Assessment of Hypertonic Saline in Moderate to Severe Asthmatics
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Salbutamol vs Long-acting Muscarinic Antagonists
The Effect of Nebulized Epinephrine in Asthma Exacerbation in Pediatric Age Group With the Standard Treatment Compared to Standard Treatment Using Improvement PRAM Score as a Primary Outcome
INhaled Salbutamol vs Placebo for the Treatment of Acute IgE-mediated Abdominal Pain From Allergic Food REactions
Salbutamol Use in Ozone Air Pollution by People With Asthma and/or Exercise Induced Bronchoconstriction (EIB)
Video Assisted Study of Salbutamol Response in Viral Wheezing
Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma
Efficacy of Intermittent Tiotropium in Early Childhood Wheezing
A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma
CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in Asthma
Deciphering a Novel and Unique Brown Adipose Tissue Depot in Women
Drug Details
- Intervention Type
- COMBINATION PRODUCT
- Total Trials
- 87